Business Context and Reporting Period
Acadia Healthcare Company, Inc. filed this Form 8-K on September 25, 2026, under Item 8.01 (Other Events). Acadia is a holding company whose subsidiaries operate behavioral healthcare facilities and services in the United States and Puerto Rico, including inpatient psychiatric, specialty treatment, residential, comprehensive treatment center, and outpatient facilities.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other current-period financial metrics. It is focused on litigation-related developments and attached settlement documents.
Material Changes Versus the Prior Comparable Period
On September 1, 2026, the U.S. District Court for the Middle District of Tennessee issued a Preliminary Approval Order for a proposed settlement of stockholder derivative claims asserted nominally on behalf of Acadia against individual defendants. The filing does not provide a comparable-period financial statement or quantify the settlement’s financial impact.
The claims relate to the previously disclosed derivative actions Solak v. Jacobs, Davydov v. Jacobs, Beard v. Jacobs, and Pfenning v. Jacobs. The latter three actions were previously disclosed as related to securities litigation settled in November 2025.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The proposed settlement remains subject to the applicable court approval process; the filing reports preliminary approval, not final approval.
- Acadia filed the July 31, 2026 Stipulation of Settlement and the Notice of Pendency and Proposed Settlement of Stockholder Derivative Action as Exhibits 99.1 and 99.2.
- The filing text does not state the settlement amount, payment obligations, insurance recoveries, allocation of costs, release terms, final approval date, or expected effect on earnings, cash flow, debt, or liquidity.
- Investors should consider the continuing legal and financial uncertainty associated with the derivative actions and related prior securities litigation.
Investor Verification Checklist
- Review Exhibits 99.1 and 99.2 for the settlement consideration, allocation of payments, releases, attorneys’ fees, and conditions to effectiveness.
- Verify whether the court grants final approval and whether any objections, appeals, or termination rights arise.
- Check subsequent filings for recognition of settlement-related expenses, insurance recoveries, cash payments, or other balance-sheet impacts.
- Reconcile this litigation update with Acadia’s latest periodic reports and disclosures concerning the November 2025 securities litigation settlement.